Trade Bristol Myers ^BMY

Could Bristol-Myers Squibb (BMY) Outperform Novartis (NVS) as CAR-T Safety Concerns Shake the Sector?

Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?

BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM

Bristol Myers Squibb Reports Positive Phase 2 Results For Arlo-cel In Multiple Myeloma

Bristol Myers' Breakthrough Cell Therapy for Blood Cancer Shows Promising Results in Mid-Stage Trial, ETPharma

Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - Daily Political

RBC Capital downgrades Novartis AG (NOVN) to a Hold

RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

Carmignac Gestion Buys New Shares in Bristol Myers Squibb Company $BMY - Zolmax

RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)

Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score

Social Security's 2027 COLA Raise Is the Biggest in 3 Years - But These 5 Dividend Stocks Pay You More

Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ... | Morningstar

Bristol Myers Squibb Company $BMY Shares Acquired by Amundi

Bristol Myers Squibb Company $BMY Shares Sold by HighTower Advisors LLC - Daily Political

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight | Valuespectrum.com

Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now

Bristol Myers Squibb Company (NYSE:BMY) Receives Average Recommendation of "Moderate Buy" from Analysts - Markets Daily

VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 1,722,230 Bristol Myers Squibb Company $BMY - Stock Observer

Paralel Advisors LLC Buys New Position in Bristol Myers Squibb Company $BMY - Daily Political

Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility

Wall Street Money Is Leaving Just As Atrium's (RNA) Pipeline Turns Real

Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc.

Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC

Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC

Bristol Myers Squibb Company $BMY Shares Acquired by Three Seasons Wealth LLC - Stock Observer

7,970 Shares in Bristol Myers Squibb Company $BMY Purchased by OceanIQ Capital LLC - Stock Observer

Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc.

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1

Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report?

Eikon Therapeutics Appoints Ching-Pin Chang As Executive VP & Chief Scientific Officer

What Does Bristol Myers Squibb (BMY) Trial Pause Mean For Its Pipeline?

Rural Pharmacies Identify Thousands of Patients at Risk of Stroke, Heart Disease, Pilot Program Finds

2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

Bristol Myers Squibb (BMY) Gains On Camzyos Data, Is The Upside Already Priced In?

Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest

Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis

3 Reasons to Sell BMY and 1 Stock to Buy Instead

Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Rating of "Moderate Buy" from Analysts

Quantitative Investment Management LLC Makes New Investment in Bristol Myers Squibb Company $BMY

Wellington Management Group LLP Has $225.53 Million Holdings in Bristol Myers Squibb Company $BMY

Benjamin Edwards Inc. Acquires 18,656 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Rating of "Moderate Buy" from Brokerages - Stock Observer

Benjamin Edwards Inc. Buys 18,656 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Wellington Management Group LLP Sells 1,592,910 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Ionis Pharmaceuticals (IONS)

Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study

Nissay Asset Management Corp Japan Has $16.04 Million Stock Position in Bristol Myers Squibb Company $BMY - Zolmax

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stake in Bristol Myers Squibb Company $BMY

Livforsakringsbolaget Skandia Omsesidigt Invests $906,000 in Bristol Myers Squibb Company $BMY - Markets Daily

Flputnam Investment Management Co. Purchases 26,360 Shares of Bristol Myers Squibb Company $BMY

Nissay Asset Management Corp Japan Purchases 14,215 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Davidson Investment Advisors Sells 15,902 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026

Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors

Bristol Myers Squibb (BMY) Stock Looks Reasonable On Earnings Yet Strong Returns Test Value

Empowered Funds LLC Purchases New Stake in Bristol Myers Squibb Company $BMY

Field & Main Bank Buys New Position in Bristol Myers Squibb Company $BMY - Stock Observer

Van ECK Associates Corp Sells 39,625 Shares of Bristol Myers Squibb Company $BMY - Daily Political

MASTERINVEST Kapitalanlage GmbH Buys Shares of 9,194 Bristol Myers Squibb Company $BMY - Daily Political

Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb

Can Atrium Therapeutics (RNA)'s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?

Public Employees Retirement System of Ohio Invests $48.43 Million in Bristol Myers Squibb Company $BMY

840,572 Shares in Bristol Myers Squibb Company $BMY Purchased by Public Employees Retirement System of Ohio - Zolmax

Glenview Trust Co Invests $5.89 Million in Bristol Myers Squibb Company $BMY

Redwood Investment Management LLC Acquires Shares of 15,992 Bristol Myers Squibb Company $BMY

Jupiter Topco LLC Makes New Investment in Bristol Myers Squibb Company $BMY

Jefferies Financial Group Inc. Takes $29.31 Million Position in Bristol Myers Squibb Company $BMY - Stock Observer

Equitable Holdings Inc. Takes Position in Bristol Myers Squibb Company $BMY

Johnson & Johnson's Psoriasis Pill Approved in China: A Game Changer in Skin Treatment, ETPharma

Bristol-Myers Squibb (BMY)'s Cellares Exit Raises Questions Over Breyanzi Growth

New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth Catalyst

Parvin Asset Management LLC Buys Shares of 19,245 Bristol Myers Squibb Company $BMY

33,855 Shares in Bristol Myers Squibb Company $BMY Bought by Pingora Partners LLC

Bcwm LLC Invests $6.36 Million in Bristol Myers Squibb Company $BMY - Markets Daily

26,390 Shares in Bristol Myers Squibb Company $BMY Purchased by Transamerica Financial Advisors LLC - Stock Observer

Caisse de depot et placement du Quebec Purchases Shares of 4,228,503 Bristol Myers Squibb Company $BMY - Markets Daily

Stonebridge Capital Management Inc. Makes New $779,000 Investment in Bristol Myers Squibb Company $BMY - Stock Observer

Will ZENBEXUS's First-in-Class CELMoD Approval Based on MRD-Negative CR Change Bristol Myers Squibb's (BMY) Narrative

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

Insider Selling: Bristol Myers Squibb (NYSE:BMY) SVP Sells $33,750.00 in Stock - Stock Observer

Primecap Management Co. CA Takes $1.44 Billion Position in Bristol Myers Squibb Company $BMY

CLARITY Act Vote: What the Crypto Bill Means for Markets

Qualcomm Stock Forecast 2026–2030: Can the Amazon AI Partnership Push QCOM Above $200?

Avalanche AVAX Price Prediction 2026, 2027, 2028 & 2030: Can AVAX Return to $100?

SK Hynix Stock Price Forecast 2026–2030: Can Memory Inventories Below 10 Days Push SKHY Above $185?

SpaceX Stock Price Prediction 2026, 2027, 2030 & 2040: How High Can SPCX Go?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

10 Best Brokers to Trade Indices in 2026

Gold Price Today, September 10: Gold Holds Near $4,400 Ahead of US PPI Data

US Dollar Weakens as Yen Rally Accelerates and Brent Crude Tops $100

US PPI Preview: Will Producer Inflation Strengthen the Case for a September Fed Rate Hike?

Apple Stock Rises After Hours as $1,999 iPhone Duo Makes Its Debut

Oil Price Today Breaks Above $100 as Iran War Escalation Fuels a New Inflation Shock

KOSPI Falls Below 7,000 as Oil and Bond Yields Pressure Korean Stocks

Oil Price Today: Brent Nears $100 After Attacks on Saudi Energy Facilities

Qualcomm Stock Jumps Nearly 11% Intraday on Amazon AI Chip Deal